A prospective study of hair transplantation combined with concentrated growth factors for the treatment of androgenetic alopecia [0.03%]
毛发移植联合生长因子注射治疗雄激素性脱发的前瞻性研究
Qirui Wang,Jing Pang,Kai Xie et al.
Qirui Wang et al.
Background: Androgenetic alopecia (AGA) is the most common form of hair loss, marked by progressive shedding and follicular miniaturization, with advanced stages leading to irreversible follicular loss. Follicular Unit Ex...
Quality of life and patient-reported side effects of low-dose oral minoxidil in treating female pattern hair loss [0.03%]
低剂量口服米诺地尔治疗女性型脱发的疗效及患者报告的不良反应
Divija Sharma,Lillian Mo,Deep Patel et al.
Divija Sharma et al.
Female pattern hair loss (FPHL) significantly affects women's well-being and quality of life (QoL), and low-dose oral minoxidil (LDOM) has increasingly gained attention as a convenient and effective treatment option. Although hypertrichosis...
Nomogram for predicting risk of relapse following complete remission in pemphigus patients [0.03%]
皮损消退的天疱疮患者复发风险预测列线图
Xuan Long,Nam Yiu,Xueting Yang et al.
Xuan Long et al.
Background: Pemphigus is a recurrent and potentially life-threatening autoimmune bullous disease. This study aimed to develop a nomogram to predict relapse risk in pemphigus patients after complete remission (CR). ...
Perceptions over biologics for psoriasis after 5 years of access in Brazil: a cross-sectional study [0.03%]
巴西皮肤病患者对生物制剂的感知变化：一项为期五年的回顾性研究
Leandro Linhares Leite,André Vicente Esteves de Carvalho,Catherine Smith
Leandro Linhares Leite
Background: Biologic therapies have transformed psoriasis management, and their incorporation into Brazil's public healthcare system (SUS) in 2019 expanded access nationwide. However, real-world utilization and perception...
Correction [0.03%]
更正通知书
On-label persistence in psoriasis after switching to guselkumab, tumor necrosis factor inhibitors, interleukin-17 inhibitors, or apremilast from other advanced therapies [0.03%]
由其他系统疗法换用古塞库单抗、肿瘤坏死因子抑制剂、白细胞介素-17抑制剂或阿普利玛后银屑病的标签持久性研究
Maryia Zhdanava,Timothy Fitzgerald,Porpong Boonmak et al.
Maryia Zhdanava et al.
Objective: To compare on-label persistence among adults with psoriasis who switched from other advanced therapies to guselkumab versus subcutaneous tumor necrosis factor inhibitors (SC TNFi), subcutaneous interleukin-17 i...
Antonio Costanzo,Federico Bardazzi,Martina Burlando et al.
Antonio Costanzo et al.
Background: The clinical definition of moderate psoriasis is debated, affecting treatment eligibility and patient outcomes. Objective: ...
Severe diffused glans penis venous malformation: successful management with 'fractional' Long-pulsed Nd: YAG laser therapy [0.03%]
弥漫性阴茎龟头静脉畸形的治疗： fractional 模式的长脉冲Nd: YAG激光疗法疗效满意
Xuan Jiang,Hongyuan Liu,Xi Yang et al.
Xuan Jiang et al.
Purpose: To assess the efficacy and safety of 'fractional' long-pulsed Nd:YAG (FLP-Nd:YAG) for the treatment of severe diffused glans penis venous malformations (GPVM). ...
Prurigo Nodularis paTient Reported burdEn of sicKness in Europe (PN TREK Europe): a cross-sectional survey of patient-reported burden of disease in patients with PN from four countries in Europe [0.03%]
欧洲瘙痒结节患者疾病负担调查（PN TREK Europe）：来自欧洲四国的皮肤瘙痒结节患者的横断面调查研究报告了疾病的患病率及疾病负担
Sonja Ständer,Min Yang,Bruno Martins et al.
Sonja Ständer et al.
Objectives: Prurigo nodularis (PN) is a chronic skin condition characterized by itchy nodules. Understanding the comprehensive patient perspective is essential for guiding treatment strategies. This study evaluated PN dis...
Management of adult vitiligo: approved topical JAK inhibitor and standard therapies [0.03%]
成人白癜疯的治疗：获批的外用JAK抑制剂和常规疗法
Maria Elisabetta Greco,Francesca Feresin,Alberto di Caro et al.
Maria Elisabetta Greco et al.
Introduction: Vitiligo is a chronic autoimmune depigmenting disorder. Ruxolitinib 1.5% cream is currently the only therapy specifically approved for its treatment. In addition, clinical guidelines recommend off label stan...